Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps

Journal of Thoracic Oncology 2026

View at publisher

Authors: Shiuan‐Chih Chen, Chin-Feng Tsai

DOI: 10.1016/j.jtho.2025.07.112

Cited by: 0

References: 5

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Chronic Myeloid Leukemia Treatments Gastrointestinal Tumor Research and Treatment

References 5